BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26342955)

  • 1. L-arginine prevents hypoxia-induced vasoconstriction in dual-perfused human placental cotyledons.
    Bednov A; Espinoza J; Betancourt A; Vedernikov Y; Belfort M; Yallampalli C
    Placenta; 2015 Nov; 36(11):1254-9. PubMed ID: 26342955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of the vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal-placental circulation.
    Myatt L; Brewer AS; Langdon G; Brockman DE
    Am J Obstet Gynecol; 1992 Jan; 166(1 Pt 1):224-30. PubMed ID: 1733199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxide induces vasoconstriction in the human placenta by stimulating thromboxane.
    Walsh SW; Wang Y; Jesse R
    Am J Obstet Gynecol; 1993 Oct; 169(4):1007-12. PubMed ID: 8238110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the L-arginine nitric oxide pathway in hypoxic fetoplacental vasoconstriction.
    Byrne BM; Howard RB; Morrow RJ; Whiteley KJ; Adamson SL
    Placenta; 1997 Nov; 18(8):627-34. PubMed ID: 9364597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide regulation of corticotropin-releasing hormone release from the human perfused placenta in vitro.
    Roe CM; Leitch IM; Boura AL; Smith R
    J Clin Endocrinol Metab; 1996 Feb; 81(2):763-9. PubMed ID: 8636301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal placental vascular responses to corticotropin-releasing hormone in vitro. Effects of variation in oxygen tension.
    Donoghue JF; Leitch IM; Boura AL; Walters WA; Giles WB; Smith R; Read MA
    Placenta; 2000 Sep; 21(7):711-7. PubMed ID: 10985975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of inhibition of nitric oxide synthase and guanylate cyclase on hydralazine-induced vasodilatation of the human fetal placental circulation.
    Leitch IM; Read MA; Boura AL; Walters WA
    Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):615-22. PubMed ID: 7529152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shear stress may stimulate release and action of nitric oxide in the human fetal-placental vasculature.
    Wieczorek KM; Brewer AS; Myatt L
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):708-13. PubMed ID: 7573230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular responses to sodium nitroprusside in the human fetal-placental circulation.
    Read MA; Giles WB; Leitch IM; Boura AL; Walters WA
    Reprod Fertil Dev; 1995; 7(6):1557-61. PubMed ID: 8743164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. U46619-mediated vasoconstriction of the fetal placental vasculature in vitro in normal and hypertensive pregnancies.
    Read MA; Leitch IM; Giles WB; Bisits AM; Boura AL; Walters WA
    J Hypertens; 1999 Mar; 17(3):389-96. PubMed ID: 10100077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-Carotene attenuates peroxide-induced vasoconstriction in the human placenta.
    Cueto SM; Romney AD; Wang Y; Walsh SW
    J Soc Gynecol Investig; 1997; 4(2):64-71. PubMed ID: 9101463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-induced fetoplacental vasoconstriction in perfused human placental cotyledons.
    Howard RB; Hosokawa T; Maguire MH
    Am J Obstet Gynecol; 1987 Nov; 157(5):1261-6. PubMed ID: 3688085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual messenger function for prostaglandin E2 (PGE2) in human placenta.
    Sastry BV; Hemontolor ME; Chance MB; Johnson RF
    Cell Mol Biol (Noisy-le-grand); 1997 May; 43(3):417-24. PubMed ID: 9193797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of NO and endothelin in hemoglobin-induced pulmonary vasoconstriction.
    Heller A; Ragaller M; Schmeck J; Flüth H; Müller M; Albrecht DM; Koch T
    Shock; 1998 Dec; 10(6):401-6. PubMed ID: 9872678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnesium sulfate attenuates peroxide-induced vasoconstriction in the human placenta.
    Walsh SW; Romney AD; Wang Y; Walsh MD
    Am J Obstet Gynecol; 1998 Jan; 178(1 Pt 1):7-12. PubMed ID: 9465795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin and the regulation of uteroplacental perfusion in nitric oxide synthase inhibition-induced fetal growth restriction.
    Thaete LG; Kushner DM; Dewey ER; Neerhof MG
    Placenta; 2005; 26(2-3):242-50. PubMed ID: 15708126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BQ123, an ETA receptor antagonist, attenuates endothelin-1-induced vasoconstriction in rat pulmonary circulation.
    Bonvallet ST; Oka M; Yano M; Zamora MR; McMurtry IF; Stelzner TJ
    J Cardiovasc Pharmacol; 1993 Jul; 22(1):39-43. PubMed ID: 7690094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of endothelin-1-induced contraction in isolated placental veins from normal full-term and preterm pregnancies.
    Gallardo V; Cruz MA; Miguel P; Carrasco G; González C
    Gen Pharmacol; 2000 May; 34(5):295-301. PubMed ID: 11368884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxide-cyclic guanosine 3',5'-monophosphate-mediated pathway.
    Clifton VL; Read MA; Leitch IM; Giles WB; Boura AL; Robinson PJ; Smith R
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2888-93. PubMed ID: 7559870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AA-2414, an antioxidant and thromboxane receptor blocker, completely inhibits peroxide-induced vasoconstriction in the human placenta.
    Walsh SW; Wang Y; Killian A
    J Pharmacol Exp Ther; 1999 Jul; 290(1):220-6. PubMed ID: 10381779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.